Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 19, 2001
Quantitative determination of intermolecular interactions with fluorinated aromatic ringsH Adams, J L Blanco, G Chessari, et al.Cancer Research|April 18, 2024
Deuterium Metabolic Imaging Differentiates Glioblastoma Metabolic Subtypes and Detects Early Response to ChemoradiotherapyJacob C M Low, Jianbo Cao, Friederike Hesse, et al.Journal of Medicinal Chemistry|April 21, 2001
Nonpeptide cholecystokinin-2 receptor agonistsS B Kalindjian, D J Dunstone, C M Low, et al.British Journal of Pharmacology|January 20, 2010
Mapping the high-affinity binding domain of 5-substituted benzimidazoles to the proximal N-terminus of the GluN2B subunit of the NMDA receptorX-K Wee, K-S Ng, H-W Leung, et al.Journal of Medicinal Chemistry|September 23, 2000
2,7-Dioxo-2,3,4,5,6,7-hexahydro-1H-benzo[h][1,4]diazonine as a new template for the design of CCK(2) receptor antagonistsI M McDonald, D J Dunstone, S B Kalindjian, et al.Journal of Medicinal Chemistry|October 13, 1995
Improving the affinity and selectivity of a nonpeptide series of cholecystokinin-B/gastrin receptor antagonists based on the dibenzobicyclo[2.2.2]octane skeletonS B Kalindjian, I M Buck, J R Cushnir, et al.Journal of Medicinal Chemistry|April 26, 1996
Non-peptide cholecystokinin-B/gastrin receptor antagonists based on bicyclic, heteroaromatic skeletonsS B Kalindjian, I M Buck, J M Davies, et al.Journal of Medicinal Chemistry|September 23, 2000
Development of peptide 3D structure mimetics: rational design of novel peptoid cholecystokinin receptor antagonistsC M Low, J W Black, H B Broughton, et al.Pageof 3